Although the prognostic value of FAP in cancers has been inconsistent throughout the literature, high expression of FAP has been shown to be an independent poor prognostic marker for outcomes in lung cancer, hepatocellular carcinoma, and colon cancer in studies with large sample sizes (n = 138-449 patients) 10-12. The gene discussed is FAP; the disease is cancer.